Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage displayGiuliana Salvatore, Richard Beers, Inger Margulies, et al.Blood|July 4, 2008
Soluble CD22 as a tumor marker for hairy cell leukemiaKakushi Matsushita, Inger Margulies, Masanori Onda, et al.Leukemia Research|February 26, 2008
PRAME expression in hairy cell leukemiaEvgeny Arons, Tara Suntum, Inger Margulies, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reactionEvgeny Arons, Inger Margulies, Lynn Sorbara, et al.Blood|November 8, 2008
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicityJohn E Weldon, Laiman Xiang, Oleg Chertov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemiaRobert J Kreitman, Maryalice Stetler-Stevenson, Inger Margulies, et al.Pageof 1